(Q37426004)

20 August 2017

Binding of thalidomide to alpha1-acid glycoprotein may be involved in its inhibition of tumor necrosis factor alpha production (English)

1 reference

20 August 2017

0 references

Turk BE

1

1 reference

20 August 2017

Jiang H

series ordinal

2

1 reference

20 August 2017

Liu JO

series ordinal

3

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 July 1996

1 reference

20 August 2017

5

1 reference

Proceedings of the National Academy of Sciences of the United States of America

inferred from page(s)

published in

1 reference

20 August 2017

93

1 reference

20 August 2017

7552-7556

1 reference

20 August 2017

15

1 reference

Alpha 1-acid glycoprotein expression in human leukocytes: possible correlation between alpha 1-acid glycoprotein and inflammatory cytokines in rheumatoid arthritis

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38783

Thalidomide inhibits the replication of human immunodeficiency virus type 1

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38783

Plasma and red blood cell protein maps: update 1993

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38783

Protection by alpha 1-acid glycoprotein against tumor necrosis factor-induced lethality

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38783

Thalidomide is an inhibitor of angiogenesis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38783

Immunosuppression by human plasma alpha 1-acid glycoprotein: importance of the carbohydrate moiety

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38783

Structure of α1-acid glycoprotein. Complete amino acid sequence, multiple amino acid substitutions, and homology with the immunoglobulins

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38783

Drug binding to human alpha-1-acid glycoprotein in health and disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38783

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38783

Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38783

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38783

Alpha 1-acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38783

Leukocyte surface origin of human alpha1-acid glycoprotein (orosomucoid).

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38783

Inhibition of platelet aggregation by native and desialised alpha-1 acid glycoprotein

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38783

Thalidomide and the immune system. 3. Simultaneous up- and down-regulation of different integrin receptors on human white blood cells.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=38783

Comparative study of the acid glycoproteins isolated from bovine serum, colostrum, and milk whey

2 September 2018

1 reference

12 December 2020

Studies on the mucoproteins of human plasma. V. Isolation and characterization of a homogeneous mucoprotein

1 reference

12 December 2020

THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS

1 reference

12 December 2020

The Amino-terminal Peptide of α1-Acid Glycoprotein

1 reference

12 December 2020

Studies on acute phase proteins of rat serum. 3. Site of synthesis of albumin and alpha 1-acid glycoprotein and the contents of these proteins in liver microsome fractions from rats suffering from induced inflammation

1 reference

12 December 2020

Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients

1 reference

12 December 2020

Thalidomide induction of bone marrow transplantation tolerance

1 reference

12 December 2020

Alpha 1-acid glycoprotein

1 reference

12 December 2020

Immunosuppressive properties of thalidomide. Inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK506

1 reference

12 December 2020

The Influence of Thalidomide on the Clinical and Immunologic Manifestation of Erythema Nodosum Leprosum

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.93.15.7552

1 reference

20 August 2017

0 references

1 reference

20 August 2017

1 reference